Approval · Notice of Compliance 7555 · 2005
RAPTIVA: Notice of Compliance 7555
Issued October 24, 2005
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 7555
- Date
- October 24, 2005
- Company
- Serono Canada Inc.
- Product type
- Biologic
- Submission
- New Drug Submission (NDS)
- Submission class
- New Active Substance (NAS)
- Therapeutic class
- Selective immunomodulating agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| RAPTIVA | 02272504 | Cancelled Post Market |
Medicinal ingredients
- EFALIZUMAB 150 MG per VIAL